New Methods for N-Glycan Sequencing Provide Structural Information in as Little as 1 Hour

Jan 2, 2019 | Biopharma, Blogs | 0 comments

As interest in N-glycan analysis grows within the biopharma industry, innovation continues allowing analyses to be done in less time with fewer and less tedious, sample preparation steps. One of these recent innovations was the release of the SCIEX Fast Glycan Technology which offers a simplified 60-minute sample prep, 5-minute separations, and automatic glycan identification. But what happens when you have an unknown peak in your sample, or if you need to confirm the structural identity of a critical glycan species? Well, developments in N-glycan analysis has continued with new methods for N-Glycan sequencing which provide complete structural elucidation in as little as 1 hour.

Having Problems With Glycan Sequencing?
Previously, carbohydrate sequencing was a tedious and time-consuming manual process. It required either consecutive addition of sequencing exoglycosidase enzymes to a single vial, which could take up to a week, or arrays of enzymes in multiple vials and parallel processing of samples which could still take a full day.

Combatting Glycan Sequencing Challenges: To break through the problems associated with older sequencing methods, two different approaches have been developed that significantly decrease manual steps and reduces the analysis time from 1–5 days to 1–2 hours. These are both semi- and fully-automated methods which can be used on your existing PA 800 Plus Pharmaceutical Analysis System together with the award-winning Fast Glycan Technology to give you the reliable data you need faster.

Differences Between Semi- and Fully- Automated Methods: The semi-automated, array-based sequencing requires only 1 hour (including reaction times, digestions, and the CE-LIF separations). However, manual pre-mixing of the enzyme mixtures is required, as well as a higher concentration of your IgG1 sample. The fully automated workflow does not require any pre-analysis of reaction arrays, but due to its serial nature, the total sequencing time was just over 2 hours. The flexibility to choose between these methods means that you can optimize your analysis for speed or ease of use depending on your needs.

If you’re interested in learning more about the new automated N-glycan sequencing methods, fill out the form on the right to watch the webinar, Sequence Your Biopharma N-Glycans in as Little as 1 Hour.

Resources:

 

How SCIEX Now empowers mass spec users to work with more control, clarity and confidence

In this interview, Andy Wilcox, Senior Market Development Manager, Aftermarket and Software, speaks with Susanna Baqué, Senior Director of Global Customer Experience, about how SCIEX Now gives customers one connected digital workspace to manage instruments, reduce time spent searching for information, resolve issues faster and keep their laboratory running more efficiently and with greater confidence.

Bioanalysis across modalities: Advancing confident decisions with modern LC‑MS strategies

As therapeutic pipelines continue to diversify, bioanalysis is being asked to do more than ever before. From small molecules to complex biologics, today’s scientists must generate high‑quality, reliable data across a growing range of molecule types and workflows, often under increasing time pressure.

The rules have changed

Regulated laboratories are evolving faster than ever. New analytical modalities, higher sample throughput, increasing regulatory scrutiny, and leaner teams are reshaping how work gets done. At the same time, expectations for data integrity, standardization, and operational efficiency continue to increase complexity and/or scope. In this environment, LC-MS software is no longer simply an instrument control platform—it has become a critical part of a laboratory’s quality management system. The question is no longer whether your lab has changed, but whether your software has evolved to support the way regulated labs operate today, and if they are ready and able to meet the demands, they will face tomorrow.

Posted by

0 Comments

Submit a Comment

Pin It on Pinterest

Share This

Share this post with your network